Vitruvia Medical AG: Issue of 6.00% Convertibel Bond 2022-2025

EQS-Ad-hoc: Vitruvia Medical AG / Key word(s): Financing Vitruvia Medical AG: Issue of 6.00% Convertibel Bond 2022-2025 26-Nov-2022 / 16:43 CET/CEST Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement.      Convertible bond Vitruvia Medical AG ("Private Placement") 6.00% 2022-2025   By resolution of the Board of Directors, Vitruvia Medical AG has resolved to issue a convertible bond ("Private Placement") of CHF 2.2 million at an interest rate of 6.00% p.a. and a term of 3 years. The issue price is set at 100% and the conversion price is EUR 2.50 and is convertible into registered shares of Vitruvia Medical AG. The funds will be used to finance existing projects (LT technologies GmbH & Co. KG), acquisitions (rebuilding of the investment portfolio) and general corporate financing.   Anglikon, 26 November 2022 Vitruvia Medical Ltd. Board of directors       26-Nov-2022 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.eqs-news.com

Language:	English
Company:	Vitruvia Medical AG
	Kesselackerstr. 18
	5611 Anglikon
	Switzerland
Phone:	[phone]
E-mail:	[e-mail]
Internet:	www.vitruvia-med.com
ISIN:	CH0461931419
WKN:	A2PDWF
Listed:	Regulated Unofficial Market in Munich
EQS News ID:	1498163

End of Announcement	EQS News Service

1498163  26-Nov-2022 CET/CEST